BUZZ - Boston Scientific shares fall as the company lowers its 2026 profit forecast

October 28 - ** The share price of medical device manufacturer Boston Scientific Corporation (BSX.N) fell 2.5% to $43.91 in pre-market trading

** BSX lowered its (link) adjusted earnings per share forecast for 2026 from the previous expectation of $3.28 to $3.32 to $3.16 to $3.18

** The company reported third-quarter revenue of $5.14 billion, exceeding analysts' expectations of $5.05 billion—data compiled by LSEG

** Third-quarter adjusted profit was $0.73 per share, higher than the expected $0.72

** As of the close of the previous trading day, BSX shares had fallen 52% so far this year

(To assist non-English speakers, Reuters automatically translates its reports into several other languages. Because automated translations may contain errors or lack necessary context, Reuters does not guarantee the accuracy of this automated translation. The automatic translation is provided solely for the convenience of readers. Reuters assumes no responsibility for any damage or loss arising from the use of this automated translation feature.)